ENTPD1 and rectal carcinoma: A subsequent study performed in the setting of human rectal carcinoma demonstrated increased CD39 expression in tumors and metastases compared with normal tissue, although it was proposed that expression of both CD39 and CD73 leads to poor prognosis 46-48.